Impact of antibiotic exposure on the risk of colorectal cancer

May-14

Gastroenterology Oncology Pharmacoepidemiology

AUTHORS : Dr Ben Boursi, Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA / Tel-Aviv University, Tel-Aviv, Israel; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel – Email: ben.boursi@sheba.health.gov.il – Profile: https://www.shebaonline.org/doctors/ben-boursi/ OR Dr Ronac Mamtani, Perelman Center for Advanced Medicine, South Pavilion, Floor 6, 3400 Civic Center Boulevard, Philadelphia, PA, 19104 – Email: ronac.mamtani@uphs.upenn.edu – Profile: https://bcan.org/staff-page/ronac-mamtani-m-d-msce/ AND also: https://www.med.upenn.edu/apps/faculty/index.php/g348/p8341217

JOURNAL : Journal of Clinical Oncology

REFERENCE: 32(S15):1599

DOI : 10.1200/jco.2014.32.15_suppl.1599

Impact of antibiotic exposure on the risk of colorectal cancer

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Colonic Diverticulosis and Uncomplicated Diverticulitis Are Associated With a Lower Not Higher Risk of Mortality When Confounding Factors Are Held Constant

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement